Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | KCNN4 | O15554 | 7/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28288580 | 0.97 | CYP1A2 (0.54) | CYP1A2KCNN4NPSR1CYP2D6MAPT | |
| SCHEMBL29559623 | 0.97 | CYP1A2 (0.54) | CYP1A2KCNN4NPSR1CYP2D6MAPT | |
| SCHEMBL28778133 | 0.97 | CYP1A2 (0.54) | CYP1A2KCNN4NPSR1CYP2D6MAPT | |
| SCHEMBL29282850 | 0.97 | CYP1A2 (0.54) | CYP1A2KCNN4NPSR1CYP2D6MAPT | |
| SCHEMBL10403424 | 0.97 | CYP1A2 (0.54) | CYP1A2KCNN4NPSR1CYP2D6MAPT | |
| SCHEMBL11522471 | 0.97 | CYP1A2 (0.54) | CYP1A2KCNN4NPSR1CYP2D6MAPT | |
| SCHEMBL10909643 | 0.97 | CYP1A2 (0.54) | CYP1A2KCNN4NPSR1CYP2D6MAPT | |
| SCHEMBL30541207 | 0.97 | CYP1A2 (0.54) | CYP1A2KCNN4NPSR1CYP2D6MAPT | |
| SCHEMBL7880822 | 0.97 | CYP1A2 (0.54) | CYP1A2KCNN4NPSR1CYP2D6MAPT | |
| Hydrogen Sulfide SCHEMBL27587806 | 0.97 | CYP1A2 (0.54) | CYP1A2KCNN4NPSR1CYP2D6MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4296 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745135-A1 | COMPOUND BASED ON THIO-GLUTARIMIDO ISOINDOLINONE SKELETON AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| EP-4745137-A1 | GLUTARIMIDE ISOINDOLINONE SKELETON-BASED COMPOUND | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| CN-122070278-A | Bifunctional protein degradation agent containing aryl substituted heteroaryl and application thereof | 标新生物医药科技(上海)有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-20260109680-A1 | METHOD FOR SYNTHESIZING 2,5-FURANDICARBOXYLIC ACID BY CARBONYLATION OF FUROIC ACID | Institute of Chemical Industry of Forest Products, CAF (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4722207-A1 | OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| EP-4685176-A1 | 2-COMPONENT FOAMS BASED ON ACETYLACETONATE AND AMINES | Henkel AG & Co. KGaA (DE) | 2026-01-28 | — | — | EP | claimed |
| US-12528974-B2 | Polishing slurry composition | KCTECH CO., LTD. (KR) | 2026-01-20 | — | — | US | claimed |
| WO-2025264177-A1 | METHOD FOR CLEAVING PROTECTING GROUPS AND ORGANIC COMPOUNDS FROM SUPPORTS | POLYPEPTIDE LABORATORIES HOLDING (PPL) AB (SE) | 2025-12-26 | — | — | WO | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| EP-4452924-B1 | PROCESS TO PREPARE VILANTEROL TRIFENATATE | HOVIONE SCIENTIA LTD (IE) | 2025-12-03 | — | — | EP | claimed |
| US-20040113127-A1 | Resistor compositions having a substantially neutral temperature coefficient of resistance and methods and compositions relating thereto | E.I. DU PONT DE NEMOURS AND COMPANY | 2004-06-17 | — | — | US | claimed |
| CN-1501911-A | Phenethanolamine derivatives for treatment of respiratory diseases | — | 2004-06-02 | — | — | CN | claimed |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-07-10 | — | — | US | claimed |
| CN-1341110-A | Novel process of preparing a benzothiazolone compound | ASTRAZENECA AG (SE) | 2002-03-20 | — | — | CN | claimed |
| EP-0918760-B1 | BIOLOGICALLY ACTIVE BENZOTHIAZOLONE ETHANAMINES | ASTRAZENECA AB (SE) | 2001-11-28 | — | — | EP | claimed |
| CN-1072214-C | Biologically active benzothiazolone ethananines | ASTRAZENECA AB (SE) | 2001-10-03 | — | — | CN | claimed |
| US-5663030-A | A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0234348-B1 | N-GLYCOSYL AMIDE DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | BAYER AG (DE) | 1991-05-29 | — | — | EP | claimed |
| US-4891425-A | IMMUNOSTIMULANTS | BAYER AKTIENGESELLSCHAFT (DE) | 1990-01-02 | — | — | US | claimed |
| US-4332962-A | RHODIUM COMPOUND AS CATALYST FOR CYCLIZATION OF A PENTADIENE | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-06-01 | — | — | US | claimed |